Eason JD - Search Results

1

Steroid-free liver transplantation using rabbit antithymocyte globulin and early tacrolimus monotherapy.

Eason JD, Nair S, Cohen AJ, Blazek JL, Loss GE Jr. Eason JD, et al. Transplantation. 2003 Apr 27;75(8):1396-9. doi: 10.1097/01.TP.0000062834.30922.FE. Transplantation. 2003. PMID: 12717237 Clinical Trial.

2

Should liver transplantation be performed for patients with hepatitis B?

Eason JD, Freeman RB Jr, Rohrer RJ, Lewis WD, Jenkins R, Dienstag J, Cosimi AB. Eason JD, et al. Transplantation. 1994 Jun 15;57(11):1588-93. Transplantation. 1994. PMID: 8009592

3

Evaluation of recombinant human soluble dimeric tumor necrosis factor receptor for prevention of OKT3-associated acute clinical syndrome.

Eason JD, Pascual M, Wee S, Farrell M, Phelan J, Boskovic S, Blosch C, Mohler KM, Cosimi AB. Eason JD, et al. Transplantation. 1996 Jan 27;61(2):224-8. doi: 10.1097/00007890-199601270-00011. Transplantation. 1996. PMID: 8600628 Clinical Trial.

4

Biological effects and fate of a soluble, dimeric, 80-kDa tumor necrosis factor receptor in renal transplant recipients who receive OKT3 therapy.

Wee S, Pascual M, Eason JD, Schoenfeld DA, Phelan J, Boskovic S, Blosch C, Mohler K, Cosimi AB. Wee S, et al. Among authors: eason jd. Transplantation. 1997 Feb 27;63(4):570-7. doi: 10.1097/00007890-199702270-00015. Transplantation. 1997. PMID: 9047153 Clinical Trial.

5

Steroid-free immunosuppression through thymoglobulin induction in liver transplantation.

Eason JD, Blazek J, Mason A, Nair S, Loss GE. Eason JD, et al. Transplant Proc. 2001 Feb-Mar;33(1-2):1470-1. doi: 10.1016/s0041-1345(00)02556-2. Transplant Proc. 2001. PMID: 11267378 No abstract available.

6

Steroid-free liver transplantation using rabbit antithymocyte globulin induction: results of a prospective randomized trial.

Eason JD, Loss GE, Blazek J, Nair S, Mason AL. Eason JD, et al. Liver Transpl. 2001 Aug;7(8):693-7. doi: 10.1053/jlts.2001.26353. Liver Transpl. 2001. PMID: 11510013 Free article. Clinical Trial.

7

Transplantation of livers from hbc Ab positive donors into HBc Ab negative recipients: a strategy and preliminary results.

Loss GE, Mason AL, Blazek J, Dick D, Lipscomb J, Guo L, Perrillo RP, Eason JD. Loss GE, et al. Among authors: eason jd. Clin Transplant. 2001;15 Suppl 6:55-8. doi: 10.1034/j.1399-0012.2001.00010.x. Clin Transplant. 2001. PMID: 11903388

8

Innovative medical management with resection for successful treatment of pulmonary mucormycosis despite diagnostic delay.

MacKenzie KM, Baumgarten KL, Helm BM, McFadden PM, Deduska NJ, Loss GE Jr, Eason JD. MacKenzie KM, et al. Among authors: eason jd. J La State Med Soc. 2002 Mar-Apr;154(2):82-5. J La State Med Soc. 2002. PMID: 12014459

9

Is obesity an independent risk factor for hepatocellular carcinoma in cirrhosis?

Nair S, Mason A, Eason J, Loss G, Perrillo RP. Nair S, et al. Hepatology. 2002 Jul;36(1):150-5. doi: 10.1053/jhep.2002.33713. Hepatology. 2002. PMID: 12085359

10

Sirolimus monotherapy in nephrotoxicity due to calcineurin inhibitors in liver transplant recipients.

Nair S, Eason J, Loss G. Nair S, et al. Liver Transpl. 2003 Feb;9(2):126-9. doi: 10.1053/jlts.2003.50026. Liver Transpl. 2003. PMID: 12548505 Free article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

126 results

Search Page

Filters